Posted Jul. 3, 2017 at 6:24 a.m.

Premium Lock GSK turns to AI to speed up drug development, invests $43M in startup

Published: 2017-07-03 06:24:21
Updated: 2017-07-03 06:24:21

GSK in Zebulon     GSK in Zebulon

GlaxoSmithKline sees the potential of using artificial intelligence to boost drug development. And its latest investment in a startup reflects that commitment. Plus: A profile of the GSK-backed startup....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders